Success Metrics

Clinical Success Rate

70.0%

Based on 7 completed trials

Completion Rate

70%(7/10)

Active Trials

0(0%)

Results Posted

57%(4 trials)

Terminated

3(25%)

Phase Distribution

Ph phase_4

25%

Ph phase_1

Ph not_applicable

17%

Ph phase_3

25%

Ph early_phase_1

Ph phase_2

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution11 total trials

Early Phase 1First-in-human

1(9.1%)

Phase 1Safety & dosage

1(9.1%)

Phase 2Efficacy & side effects

1(9.1%)

Phase 3Large-scale testing

3(27.3%)

Phase 4Post-market surveillance

3(27.3%)

N/ANon-phased studies

2(18.2%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

70.0%

7 of 10 finished

Non-Completion Rate

30.0%

3 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Active(1)

Completed(7)

Terminated(3)

Other(1)

Detailed Status

Completed7

Terminated3

Enrolling by invitation1

unknown1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

70.0%

Most Advanced

Phase 4

Trials by Phase

Early Phase 11 (9.1%)

Phase 11 (9.1%)

Phase 21 (9.1%)

Phase 33 (27.3%)

Phase 43 (27.3%)

N/A2 (18.2%)

Trials by Status

enrolling_by_invitation18%

unknown18%

terminated325%

completed758%

Recent Activity

0 active trials

Showing 5 of 12

completedphase_1

Simplified Algorithm for the Prevention of Postoperative Nausea and Vomiting in an Oncological Hospital

NCT04411069

completednot_applicable

Real-time Decision Support for Postoperative Nausea and Vomiting (PONV) Prophylaxis

NCT02625181

View all 12 trials

Clinical Trials (12)

Showing 12 of 12 trials

NCT02858310Phase 1

E7 TCR T Cells for Human Papillomavirus-Associated Cancers

Completed

NCT07015528Early Phase 1

Assessment of Drug Liking In Peri-procedural Clinical Settings

Enrolling By Invitation

NCT05065567Phase 3

Haloperidol, Droperidol, Ondansetron in Cannabis Hyperemesis

Terminated

NCT04411069Phase 2

Simplified Algorithm for the Prevention of Postoperative Nausea and Vomiting in an Oncological Hospital

Completed

NCT02625181Not Applicable

Real-time Decision Support for Postoperative Nausea and Vomiting (PONV) Prophylaxis

Completed

NCT02600741

Family Intervention in Recent Onset Schizophrenia Treatment (FIRST)

Completed

NCT01406860Not Applicable

Droperidol Versus Metoclopramide + Diphenhydramine for the Treatment of Primary Headaches

Terminated

NCT02744495Phase 3

Prophylaxis of Postoperative Nausea and Vomiting After Cardiac Surgery

Completed

NCT01679093Phase 3

Antagonism Research Between Antiemetics Agents and Acetaminophen in Thyroidectomy's Post-operative Analgesia.

Completed

NCT00445055Phase 4

Evaluation of 2 Doses of Intravenous Droperidol in the Prevention of Postoperative Nausea

Terminated

NCT00702442Phase 4

Role of Droperidol in Postoperative Vomiting

Completed

NCT00209885Phase 4

Optimal Multimodal Analgesia in Laparoscopic Cholecystectomy

Unknown

All 12 trials loaded

Drug Details

Intervention Type: DRUG
Total Trials: 12